Torrent Pharmaceuticals Ltd vs Unichem Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Torrent Pharmaceuticals Ltd is ₹ 4191 as of 30 Apr 15:30 . The P/E Ratio of Torrent Pharmaceuticals Ltd changed from 34.3 on March 2021 to 57.3 on March 2025 . This represents a CAGR of 10.81% over 5 yearsThe P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 35.5 on March 2025 . This represents a CAGR of -10.95% over 5 years The Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 43002 crore on March 2021 to ₹ 109468 crore on March 2025 . This represents a CAGR of 20.55% over 5 yearsThe Market Cap of Unichem Laboratories Ltd changed from ₹ 2177 crore on March 2021 to ₹ 4877 crore on March 2025 . This represents a CAGR of 17.50% over 5 years The revenue of Torrent Pharmaceuticals Ltd for the Dec '25 is ₹ 3290 crore as compare to the Sep '25 revenue of ₹ 3275 crore. This represent the growth of 0.46% The revenue of Unichem Laboratories Ltd for the Dec '25 is ₹ 808.49 crore as compare to the Sep '25 revenue of ₹ 599.93 crore. This represent the growth of 34.76% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '25 is ₹ 1065 crore as compare to the Sep '25 ebitda of ₹ 1043 crore. This represent the growth of 2.11% The ebitda of Unichem Laboratories Ltd for the Dec '25 is ₹ 332.1 crore as compare to the Sep '25 ebitda of ₹ 28.89 crore. This represent the growth of 1049% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 635 crore over 7 quarters. This represents a CAGR of 20.68% The net profit of Unichem Laboratories Ltd changed from ₹ 2.07 crore to ₹ 264.29 crore over 7 quarters. This represents a CAGR of 1497.69% The Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 10.76 % on March 2025 . This represents a CAGR of -27.04% over 5 yearsThe Dividend Payout of Unichem Laboratories Ltd changed from 52.07 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

About Unichem Laboratories Ltd

Unichem Laboratories Limited manufactures active pharmaceutical ingredients.
The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
The Baddi plant was approved by UK MHRA and MCC (South Africa).
The company received ISO 9001:2000 for all their plants and corporate office.

FAQs for the comparison of Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd

Which company has a larger market capitalization, Torrent Pharmaceuticals Ltd or Unichem Laboratories Ltd?

Market cap of Torrent Pharmaceuticals Ltd is 141,859 Cr while Market cap of Unichem Laboratories Ltd is 2,740 Cr

What are the key factors driving the stock performance of Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd?

The stock performance of Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd?

As of May 4, 2026, the Torrent Pharmaceuticals Ltd stock price is INR ₹4191.5. On the other hand, Unichem Laboratories Ltd stock price is INR ₹389.3.

How do dividend payouts of Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd compare?

To compare the dividend payouts of Torrent Pharmaceuticals Ltd and Unichem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.